A Survey of Diagnostic Practices and the Use of Epoprostenol In Patients With Primary Pulmonary Hypertension
- 1 November 1998
- Vol. 114 (5) , 1269-1275
- https://doi.org/10.1378/chest.114.5.1269
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Inhaled nitric oxide, right ventricular efficiency, and pulmonary vascular mechanics: Selective vasodilation of small pulmonary vessels during hypoxic pulmonary vasoconstrictionThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- Adenosine effectively controls pulmonary hypertension after cardiac operationsThe Annals of Thoracic Surgery, 1996
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Hypothyroidism and Primary Pulmonary Hypertension: An Autoimmune Pathogenetic Link?Annals of Internal Medicine, 1993
- Haemodynamic requirements for an ideal pulmonary vasodilatorEuropean Heart Journal, 1988
- Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failureInternational Journal of Cardiology, 1988
- The role of prostaglandins in the nociceptive response induced by intraperitoneal injection of zymosan in miceBritish Journal of Pharmacology, 1987
- Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).Heart, 1987
- The hyperalgesic effects of prostacyclin and prostaglandin E2Prostaglandins, 1978